NDC 0074-2320 – Rinvoq

Upadacitinib 1 mg/mL · Solution · Oral

Human Prescription Drug

Product NDC0074-2320

Product details

Brand name
Rinvoq
Generic name
Upadacitinib
Labeler
AbbVie Inc.
Dosage form
Solution
Route
Oral
Marketing category
NDA · NDA218347
Marketed since
April 26, 2024
Listing expires
December 31, 2027
Pharmacologic class
Janus Kinase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Rinvoq →

Package NDC codes (2)

Package NDCDescriptionSince
0074-2320-011 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLEApr 26, 2024
0074-2320-70 sample1 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLEApr 26, 2024

Other Rinvoq products